In Brief
This article was originally published in The Rose Sheet
Executive Summary
ICCR’s new centralized website provides access to documents on topics of interest and other information on the coalition. More news in brief.
You may also be interested in...
Portfolio Firm Glansaol Looks To Make Mark In Prestige, Led By Ex-Revlon CEO
More deals may be on the horizon for portfolio company Glansaol following its announced market entry with the acquisition of three prestige brands.
ICCR To Consider Regulatory Harmonization On Allergen Issues
At FDA’s June 2 public meeting to prepare for the eighth iteration of the International Cooperation on Cosmetics Regulation, the agency recapped accomplishments from ICCR-7 and outlined cosmetic regulatory topics to be addressed at ICCR-8. Allergens are up for discussion, as are trace materials.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”